May not be tolerable enough for widespread use
The companys entry into obesity combines this antibody expertise with GLP-1 biology, however, its focus is testing whether muscle-preserving antibodies, including trevogrumab, a myostatin inhibitor, can be combined with semaglutide to address the lean-mass loss associated with GLP-1 monotherapy
Think of it as your nutritional safety net to support you on your weight loss journey
Focus on adequate intake of iron, zinc, vitamin D, and B vitamins (particularly B12) through a varied, nutrient-dense diet
Glucagon receptor agonism increases hepatic glucose output and is hypothesised to promote lipolysis and increase energy expenditure, though the magnitude of this effect in humans is uncertain and context-dependent